Abstract
Amphiphilic cross-linked poly (vinyl alcohol-methyl methacrylate) (PVA-PMMA) copolymer nanoparticles (NPs) were prepared using a two-step process. Unlike other polymers, which are typically produced via direct polymerization, PVA is produced from the hydrolysis of polyvinyl acetate (PVAc). Therefore, in the first part of the project, copolymeric PVAc-PMMA NPs were prepared by using the radical emulsion polymerization method in different concentrations of BDOD (0–10% mol.) and water: methanol compositions. Conversion degree, morphology, particle size, and polymerization rate of non-agglomerated samples were evaluated. The optimal sample that synthesized in water: methanol % (90:10) as polymerization medium and 2.5% mol. crosslinker was hydrolyzed by 0.6 M NaOH solution. To confirm the hydrolysis reaction, FE-SEM, FT-IR, DLS, 1H NMR, and TGA tests were performed. The optimal sample was loaded by methotrexate (MTX), and drug release investigated at different times by UV-vis spectrophotometry. The sustained and pH-responsive profile of drug release in vitro was observed, and 47.24% of the drug was released at pH = 7.4 and 65.39% at pH = 5.8 after 96 h. Also, the MTT assay and dual-fluorescent acridine orange/propidium iodide assay showed that drug-loaded nanocarriers exhibited anticancer activity as applied to MCF-7 cells.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Polymeric Materials and Polymeric Biomaterials
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
